View ValuationFRX Innovations 将来の成長Future 基準チェック /06現在、 FRX Innovationsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長4.5%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jan 28FRX Innovations Listing Transfer to NEX from Tier 2 Effective January 29TSX Venture Exchange has accepted for filing documentation with respect to Stock Purchase Agreement (the "Agreement") dated November 27, 2024, between the Company and FRX Acquisition Inc., a Delaware corporation ("Buyer"), whereby the Company will sell all equity interests in its wholly-owned operating subsidiary FRX Polymers Inc. (the "Subsidiary"). In accordance with TSX Venture Policy 2.5, the Company has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the open on January 29, 2025, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Toronto to NEX. The trading symbol for the Company will change from FRXI to FRXI.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. As of January 29, 2025, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The Company is classified as a 'Resin, Synthetic Rubber, and Artificial and Synthetic Fibres and Filaments Manufacturing' company.お知らせ • Jan 24FRX Acquisition, Inc. completed the acquisition of Frx Polymers Inc. from FRX Innovations Inc. (TSXV:FRXI).FRX Acquisition, Inc. agreed to acquire Frx Polymers Inc. from FRX Innovations Inc. (TSXV:FRXI) for $1.65849 million on November 27, 2024. As part of consideration, $1.5 million is paid towards common equity and $0.15849 million is paid towards convertible debt of Frx Polymers Inc. In case of termination of transaction, FRX Innovations Inc. will pay a termination fee of $0.50 million. Transaction is also subject to the approval of FRX Innovations's shareholders pursuant to the Canada Business Corporations Act (the “CBCA”) and minority Shareholders pursuant to MI 61-101, the approval of the TSX Venture Exchange and the approval of the Belgian Interfederal Screening Committee. As of December 27, 2024 the transaction was approved by the shareholders of FRX Innovations Inc. (TSXV:FRXI). FRX Acquisition, Inc. completed the acquisition of Frx Polymers Inc. from FRX Innovations Inc. (TSXV:FRXI) on January 23, 2025.お知らせ • Oct 18FRX Innovations Inc., Annual General Meeting, Dec 16, 2024FRX Innovations Inc., Annual General Meeting, Dec 16, 2024.New Risk • Jun 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (33% average weekly change). Earnings have declined by 9.1% per year over the past 5 years. Market cap is less than US$10m (CA$5.92m market cap, or US$4.31m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (19% increase in shares outstanding). Revenue is less than US$5m (US$3.0m revenue).お知らせ • Mar 03FRX Innovations Inc. announced that it has received CAD 0.945313 million in fundingFRX Innovations Inc. announced a non-brokered private placement of 18,906,266 units of the company at a price of CAD 0.05 per unit for the gross proceeds of CAD 945,313 on March 1, 2024. Each Unit consists of one common share of the company. Each warrant shall entitle the holder thereof to purchase one additional common share of the company at a 100% price premium of CAD 0.10 at any time on or before the 24-month anniversary of the date of closing.お知らせ • Dec 07FRX Innovations Inc. Announces Commercial Product Launches of New Nofia® Based ProductsFRX Innovations Inc. announced commercial product launches of new Nofia® based products by two globally recognized chemical companies, and one important regional producer, this quarter. Commercial shipments will commence this month against purchase orders, for one of these applications. Each application is poised to significantly contribute to FRX's projected year-over-year revenue growth for 2024. The first is expected to generate USD 1 million in Nofia® product sales in 2024, and the others in excess of USD 0.5 million. FRX expects to realize a contribution margin of about 45% over variable costs on both pieces of business. Two applications leverage the unique benefits which FRX's Nofia ® flame retardants bring in polyurethane, targeting highly attractive markets such as Clean Energy, and Automotive. This is yet further evidence that top chemical companies around the world, with access to all available technologies, are choosing Nofia products from FRX to meet the high-performance standards required for these markets, at a competitive cost for the benefits provided. The third new product is being introduced by a major Asian specialty chemicals manufacturer with global leadership in polyester. FRX delivers a range of Nofia ® products suitable for use in polyester applications, such as textiles used in transportation and hospitality markets, films used in automotive applications, films used in electronic devices and structural foam used in transportation and building and construction applications. Strong Sales Pipeline: FRX's sales pipeline consists of 237 customer projects. Nearly 70% (187 customer projects) are less than 12 months old. These customers are turning to FRX due to an urgency to replace their lines of legacy brominated and PFAS flame retardants, with 36% of all customer projects focused on PFAS replacement.Reported Earnings • Dec 01Third quarter 2023 earnings released: US$0.02 loss per share (vs US$0.022 loss in 3Q 2022)Third quarter 2023 results: US$0.02 loss per share. Revenue: US$629.1k (up 58% from 3Q 2022). Net loss: US$2.03m (loss widened 15% from 3Q 2022). Revenue is forecast to grow 87% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Canada are expected to remain flat.Reported Earnings • Sep 03Second quarter 2023 earnings released: US$0.012 loss per share (vs US$0.05 loss in 2Q 2022)Second quarter 2023 results: US$0.012 loss per share (improved from US$0.05 loss in 2Q 2022). Revenue: US$1.48m (up 13% from 2Q 2022). Net loss: US$1.18m (loss narrowed 56% from 2Q 2022). Revenue is forecast to grow 74% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Canada are expected to remain flat.お知らせ • Aug 03FRX Innovations Inc. Appoints Patrick Muezers to Its Board of DirectorsFRX Innovations announced the appointment of Mr. Patrick Muezers to its Board of Directors. Mr. Muezers has over twenty years of experience in building and growing specialty chemical companies globally. Most recently, he successfully completed an M&A transaction for Polyscope Polymers B.V. ("Polyscope"), a European specialty plastics company that he founded and grew through to a successful exit. During his tenure as Managing Director of Polyscope, Mr. Muezers attracted a top-tier senior leadership team and a world-class Board of Directors with deep market expertise. In a short span, Polyscope became a highly profitable enterprise, servicing the plastics industry with customers around the world. He currently also serves on the Advisory Board of Arion, and previously served for seven years on the board of RAI Automotive Group. As a result of his growing commitments as CEO of Platinum Group Metals, contemporaneously with the appointment of Mr. Patrick Muezers, Mr. Frank Hallam will be transitioning from the FRX Board of Directors, where he served as Director and Chair of the Company's audit committee.New Risk • Jul 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.2m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 20% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Revenue is less than US$5m (US$2.6m revenue). Market cap is less than US$100m (CA$19.4m market cap, or US$14.7m).New Risk • Jul 15New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$8.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.2m free cash flow). Earnings have declined by 21% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Shareholders have been diluted in the past year (24% increase in shares outstanding). Revenue is less than US$5m (US$2.6m revenue). Market cap is less than US$100m (CA$16.9m market cap, or US$12.8m).Reported Earnings • Jul 12Full year 2022 earnings released: US$0.23 loss per share (vs US$0.35 loss in FY 2021)Full year 2022 results: US$0.23 loss per share. Revenue: US$3.11m (down 49% from FY 2021). Net loss: US$14.2m (loss widened 62% from FY 2021). Revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 1.8% decline forecast for the Chemicals industry in Canada.お知らせ • Jan 11FRX Innovations Inc. announced that it has received CAD 1.624804 million in fundingOn January 11, 2023, FRX Innovations Inc. closed the transaction. The company issued 5,446,012 units at an issue price of CAD 0.30 for the gross proceeds of CAD 1,633,804.Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.022 loss per share (vs US$0.072 loss in 3Q 2021)Third quarter 2022 results: US$0.022 loss per share (improved from US$0.072 loss in 3Q 2021). Revenue: US$397.2k (down 74% from 3Q 2021). Net loss: US$1.76m (loss narrowed 5.4% from 3Q 2021). Revenue is forecast to grow 43% p.a. on average during the next 3 years, compared to a 3.3% decline forecast for the Chemicals industry in Canada.お知らせ • Nov 26FRX Innovations Inc. announced that it expects to receive CAD 1.5 million in fundingFRX Innovations Inc. announced a non brokered private placement of 5,000,000 units at a price of CAD 0.30 per unit for gross proceeds of CAD 1,500,000 on November 24, 2022. Each unit consists of one common share of the company and one common share purchase warrant of the company. Each warrant shall entitle the holder thereof to purchase one additional common share of the company at a price of CAD 0.40 per unit at any time on or before the 36-month anniversary of the date of closing. Commissions of CAD 29,840 and 99,468 warrants were paid in association to the transaction. All securities issued pursuant to the transaction will be subject to a statutory hold period ending on March 25, 2023. On the same day the company issued 2,073,345 units of the company at a price per unit of CAD 0.30 per unit , for aggregate gross proceeds of CAD 622,004 in its first tranche.Board Change • Nov 16No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 8 non-independent directors. Director James Cassina was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.Reported Earnings • Sep 02Second quarter 2022 earnings released: US$0.05 loss per share (vs US$0.062 loss in 2Q 2021)Second quarter 2022 results: US$0.05 loss per share. Revenue: US$1.31m (up 10% from 2Q 2021). Net loss: US$2.70m (loss widened 81% from 2Q 2021).Reported Earnings • Jun 09First quarter 2022 earnings released: US$0.17 loss per share (vs US$0.062 loss in 1Q 2021)First quarter 2022 results: US$0.17 loss per share (down from US$0.062 loss in 1Q 2021). Revenue: US$1.10m (down 38% from 1Q 2021). Net loss: US$4.64m (loss widened 214% from 1Q 2021).Board Change • May 25No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 8 non-independent directors. Director James Cassina was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、FRX Innovations は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TSXV:FRXI - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/20233-8-5-5N/A6/30/20233-8-5-5N/A3/31/20233-11-8-8N/A12/31/20223-14-5-5N/A9/30/20225-14-5-4N/A6/30/20226-14-5-4N/A3/31/20226-14-2-2N/A12/31/20216-9-4-3N/A9/30/20216-8-2-1N/A12/31/20205-6-3-3N/A12/31/20196-8-6-5N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: FRXIの予測収益成長が 貯蓄率 ( 2.2% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: FRXIの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: FRXIの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: FRXIの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: FRXIの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: FRXIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/10/12 01:16終値2024/07/15 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋FRX Innovations Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関William GregozeskiGreenridge Global LLCBradley SorensenZacks Small-Cap Research
お知らせ • Jan 28FRX Innovations Listing Transfer to NEX from Tier 2 Effective January 29TSX Venture Exchange has accepted for filing documentation with respect to Stock Purchase Agreement (the "Agreement") dated November 27, 2024, between the Company and FRX Acquisition Inc., a Delaware corporation ("Buyer"), whereby the Company will sell all equity interests in its wholly-owned operating subsidiary FRX Polymers Inc. (the "Subsidiary"). In accordance with TSX Venture Policy 2.5, the Company has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the open on January 29, 2025, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Toronto to NEX. The trading symbol for the Company will change from FRXI to FRXI.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. As of January 29, 2025, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The Company is classified as a 'Resin, Synthetic Rubber, and Artificial and Synthetic Fibres and Filaments Manufacturing' company.
お知らせ • Jan 24FRX Acquisition, Inc. completed the acquisition of Frx Polymers Inc. from FRX Innovations Inc. (TSXV:FRXI).FRX Acquisition, Inc. agreed to acquire Frx Polymers Inc. from FRX Innovations Inc. (TSXV:FRXI) for $1.65849 million on November 27, 2024. As part of consideration, $1.5 million is paid towards common equity and $0.15849 million is paid towards convertible debt of Frx Polymers Inc. In case of termination of transaction, FRX Innovations Inc. will pay a termination fee of $0.50 million. Transaction is also subject to the approval of FRX Innovations's shareholders pursuant to the Canada Business Corporations Act (the “CBCA”) and minority Shareholders pursuant to MI 61-101, the approval of the TSX Venture Exchange and the approval of the Belgian Interfederal Screening Committee. As of December 27, 2024 the transaction was approved by the shareholders of FRX Innovations Inc. (TSXV:FRXI). FRX Acquisition, Inc. completed the acquisition of Frx Polymers Inc. from FRX Innovations Inc. (TSXV:FRXI) on January 23, 2025.
お知らせ • Oct 18FRX Innovations Inc., Annual General Meeting, Dec 16, 2024FRX Innovations Inc., Annual General Meeting, Dec 16, 2024.
New Risk • Jun 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (33% average weekly change). Earnings have declined by 9.1% per year over the past 5 years. Market cap is less than US$10m (CA$5.92m market cap, or US$4.31m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (19% increase in shares outstanding). Revenue is less than US$5m (US$3.0m revenue).
お知らせ • Mar 03FRX Innovations Inc. announced that it has received CAD 0.945313 million in fundingFRX Innovations Inc. announced a non-brokered private placement of 18,906,266 units of the company at a price of CAD 0.05 per unit for the gross proceeds of CAD 945,313 on March 1, 2024. Each Unit consists of one common share of the company. Each warrant shall entitle the holder thereof to purchase one additional common share of the company at a 100% price premium of CAD 0.10 at any time on or before the 24-month anniversary of the date of closing.
お知らせ • Dec 07FRX Innovations Inc. Announces Commercial Product Launches of New Nofia® Based ProductsFRX Innovations Inc. announced commercial product launches of new Nofia® based products by two globally recognized chemical companies, and one important regional producer, this quarter. Commercial shipments will commence this month against purchase orders, for one of these applications. Each application is poised to significantly contribute to FRX's projected year-over-year revenue growth for 2024. The first is expected to generate USD 1 million in Nofia® product sales in 2024, and the others in excess of USD 0.5 million. FRX expects to realize a contribution margin of about 45% over variable costs on both pieces of business. Two applications leverage the unique benefits which FRX's Nofia ® flame retardants bring in polyurethane, targeting highly attractive markets such as Clean Energy, and Automotive. This is yet further evidence that top chemical companies around the world, with access to all available technologies, are choosing Nofia products from FRX to meet the high-performance standards required for these markets, at a competitive cost for the benefits provided. The third new product is being introduced by a major Asian specialty chemicals manufacturer with global leadership in polyester. FRX delivers a range of Nofia ® products suitable for use in polyester applications, such as textiles used in transportation and hospitality markets, films used in automotive applications, films used in electronic devices and structural foam used in transportation and building and construction applications. Strong Sales Pipeline: FRX's sales pipeline consists of 237 customer projects. Nearly 70% (187 customer projects) are less than 12 months old. These customers are turning to FRX due to an urgency to replace their lines of legacy brominated and PFAS flame retardants, with 36% of all customer projects focused on PFAS replacement.
Reported Earnings • Dec 01Third quarter 2023 earnings released: US$0.02 loss per share (vs US$0.022 loss in 3Q 2022)Third quarter 2023 results: US$0.02 loss per share. Revenue: US$629.1k (up 58% from 3Q 2022). Net loss: US$2.03m (loss widened 15% from 3Q 2022). Revenue is forecast to grow 87% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Canada are expected to remain flat.
Reported Earnings • Sep 03Second quarter 2023 earnings released: US$0.012 loss per share (vs US$0.05 loss in 2Q 2022)Second quarter 2023 results: US$0.012 loss per share (improved from US$0.05 loss in 2Q 2022). Revenue: US$1.48m (up 13% from 2Q 2022). Net loss: US$1.18m (loss narrowed 56% from 2Q 2022). Revenue is forecast to grow 74% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Canada are expected to remain flat.
お知らせ • Aug 03FRX Innovations Inc. Appoints Patrick Muezers to Its Board of DirectorsFRX Innovations announced the appointment of Mr. Patrick Muezers to its Board of Directors. Mr. Muezers has over twenty years of experience in building and growing specialty chemical companies globally. Most recently, he successfully completed an M&A transaction for Polyscope Polymers B.V. ("Polyscope"), a European specialty plastics company that he founded and grew through to a successful exit. During his tenure as Managing Director of Polyscope, Mr. Muezers attracted a top-tier senior leadership team and a world-class Board of Directors with deep market expertise. In a short span, Polyscope became a highly profitable enterprise, servicing the plastics industry with customers around the world. He currently also serves on the Advisory Board of Arion, and previously served for seven years on the board of RAI Automotive Group. As a result of his growing commitments as CEO of Platinum Group Metals, contemporaneously with the appointment of Mr. Patrick Muezers, Mr. Frank Hallam will be transitioning from the FRX Board of Directors, where he served as Director and Chair of the Company's audit committee.
New Risk • Jul 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.2m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 20% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Revenue is less than US$5m (US$2.6m revenue). Market cap is less than US$100m (CA$19.4m market cap, or US$14.7m).
New Risk • Jul 15New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$8.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.2m free cash flow). Earnings have declined by 21% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Shareholders have been diluted in the past year (24% increase in shares outstanding). Revenue is less than US$5m (US$2.6m revenue). Market cap is less than US$100m (CA$16.9m market cap, or US$12.8m).
Reported Earnings • Jul 12Full year 2022 earnings released: US$0.23 loss per share (vs US$0.35 loss in FY 2021)Full year 2022 results: US$0.23 loss per share. Revenue: US$3.11m (down 49% from FY 2021). Net loss: US$14.2m (loss widened 62% from FY 2021). Revenue is forecast to grow 66% p.a. on average during the next 3 years, compared to a 1.8% decline forecast for the Chemicals industry in Canada.
お知らせ • Jan 11FRX Innovations Inc. announced that it has received CAD 1.624804 million in fundingOn January 11, 2023, FRX Innovations Inc. closed the transaction. The company issued 5,446,012 units at an issue price of CAD 0.30 for the gross proceeds of CAD 1,633,804.
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.022 loss per share (vs US$0.072 loss in 3Q 2021)Third quarter 2022 results: US$0.022 loss per share (improved from US$0.072 loss in 3Q 2021). Revenue: US$397.2k (down 74% from 3Q 2021). Net loss: US$1.76m (loss narrowed 5.4% from 3Q 2021). Revenue is forecast to grow 43% p.a. on average during the next 3 years, compared to a 3.3% decline forecast for the Chemicals industry in Canada.
お知らせ • Nov 26FRX Innovations Inc. announced that it expects to receive CAD 1.5 million in fundingFRX Innovations Inc. announced a non brokered private placement of 5,000,000 units at a price of CAD 0.30 per unit for gross proceeds of CAD 1,500,000 on November 24, 2022. Each unit consists of one common share of the company and one common share purchase warrant of the company. Each warrant shall entitle the holder thereof to purchase one additional common share of the company at a price of CAD 0.40 per unit at any time on or before the 36-month anniversary of the date of closing. Commissions of CAD 29,840 and 99,468 warrants were paid in association to the transaction. All securities issued pursuant to the transaction will be subject to a statutory hold period ending on March 25, 2023. On the same day the company issued 2,073,345 units of the company at a price per unit of CAD 0.30 per unit , for aggregate gross proceeds of CAD 622,004 in its first tranche.
Board Change • Nov 16No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 8 non-independent directors. Director James Cassina was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.
Reported Earnings • Sep 02Second quarter 2022 earnings released: US$0.05 loss per share (vs US$0.062 loss in 2Q 2021)Second quarter 2022 results: US$0.05 loss per share. Revenue: US$1.31m (up 10% from 2Q 2021). Net loss: US$2.70m (loss widened 81% from 2Q 2021).
Reported Earnings • Jun 09First quarter 2022 earnings released: US$0.17 loss per share (vs US$0.062 loss in 1Q 2021)First quarter 2022 results: US$0.17 loss per share (down from US$0.062 loss in 1Q 2021). Revenue: US$1.10m (down 38% from 1Q 2021). Net loss: US$4.64m (loss widened 214% from 1Q 2021).
Board Change • May 25No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 8 non-independent directors. Director James Cassina was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity.